Abstract
The concept of treating effusions due to pleura or peritoneal carcinosis with radioactive colloids was introduced 40 years ago [2]. For this purpose, 63Zn sulfide and later on 198Au colloid have been used [2, 3]. Both cases involved the application of beta and gamma emitters, where the beta emission was almost exclusively responsible for the therapeutic effect. As the gamma radiation necessitated inconvenient precautions for radiation protection [1], radioactive colloids with pure beta emission have been developed since 1954 for intracavitary radionuclide therapy [4–7]. This concerned primarily 32P chromium phosphate and 90Y silicate; 169Er citrate and 186Re sulfate were also recommended. Whereas the two latter compounds were not applied on a large scale, the 90Y colloid has for almost 30 years proved to be the most suitable substance for the treatment of malignant effusions in pleura and peritoneum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Becker J, Scheer KE (1961) Die lokalisierte Applikation künstlich radioaktiver Isotope. In: Höfer K (ed) Künstliche radioaktive Isotope in Physiologie, Diagnostik und Therapie, vol 2. Springer, Berlin Göttingen Heidelberg, p 702
Müller JH (1945) Über die Verwendung von künstlich radioaktiven Isotopen zur Erzielung von lokalisierten biologischen Strahlenwirkungen. Experientia 1:199
Müller JH (1961) Interne Tumortherapie mit künstlich radioaktiven Isotopen. In: Künstliche radioaktive Isotope in Physiologie, Diagnostik und Therapie, vol 2. Springer, Berlin Göttingen Heidelberg, p 785
Riccabona G (1978) Intracavitäre Isotopentherapie, klinische Bedeutung in Diagnostik und Therapie. Nuc Med, p 698
Riccabona G (1983) Therapy with radionuclides — Actual state of the art. In: Nuclearmedi-cine, imaging of metabolism and organ function. Schattauer, Stuttgart, p 910
Root SW, Taylor MP, Andrews GA, Knisely RM (1954) Distribution of colloidal radioactive chromic phosphate after intracavitary administration. Radiology 63:251
Siegel EP, Hart HE, Brothers M, Spencer H, Laszlo D (1956) Radio-yttrium (90Y) for the palliative treatment of effusions due to malignancy. JAMA 161:499
Weisberger AS, Levine B, Storaasli JP (1955) Use of nitrogen mustard in treatment of serous effusions of neoplastic origin. JAMA 159:1704
Zaloznik AJ, Oswald SG, Langin M (1983) Intrapleural tetracycline in malignant pleural effusions, a randomized study. Cancer 51:752–755
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Riccabona, G. (1986). Treatment of Pleural and Peritoneal Carcinosis with Radioactive Colloids. In: Winkler, C. (eds) Nuclear Medicine in Clinical Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70947-0_52
Download citation
DOI: https://doi.org/10.1007/978-3-642-70947-0_52
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16164-6
Online ISBN: 978-3-642-70947-0
eBook Packages: Springer Book Archive